Ng George K 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Ng George K（CIK 1638744）在 1 家公司共报告 11 笔 SEC Form 4 内部人交易（最近一笔 2026-08-11）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-11 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | 买入 | 1,600 | $0 |
| 2026-07-01 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | 买入 | 3,057 | $5,900 |
| 2026-06-16 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | 买入 | 2,465 | $5,472 |
| 2026-06-01 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | 买入 | 2,129 | $5,472 |
| 2026-05-19 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | 买入 | 1,843 | $5,474 |
| 2026-05-19 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | 买入 | 1,843 | $5,474 |
| 2026-05-01 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | 买入 | 2,034 | $5,471 |
| 2026-04-30 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | 买入 | 2,136 | $5,425 |
| 2026-04-30 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | 买入 | 1,843 | $5,474 |
| 2026-04-17 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | 买入 | 1,843 | $5,474 |
| 2026-04-01 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | 买入 | 2,136 | $5,425 |
来源：SEC Form 4 申报文件 · 截至 2026-08-11